What compliance standards apply to a bioimpedance (BIA) device sold into Canada?

A BIA device sold into Canada must hold an active Health Canada Class II Medical Device Licence (MDALL). The factory must hold ISO 13485:2016 quality management system certification with scope covering the device category. Electrical safety to CAN/CSA-C22.2 No.60601-1 (the Canadian adoption of IEC 60601-1) is required. Compliance document verification — including querying the MDALL database at mdall.hc-sc.gc.ca — should be conducted before any factory is engaged.

What compliance standards apply to a bioimpedance (BIA) device sold into Australia?

A BIA device sold into Australia must appear in the TGA Australian Register of Therapeutic Goods (ARTG) as a Class IIa medical device. The factory must hold ISO 13485:2016 quality management system certification. Electrical safety compliance to AS/NZS 3551 (medical electrical equipment management in Australian healthcare facilities) applies to the device once in service. ARTG registration is verifiable at tga.gov.au/resources/artg.

What is the difference between IEC 60601-1 and AS/NZS 3551?

IEC 60601-1 is the global electrical safety standard for medical electrical equipment, covering design and manufacturing requirements. CAN/CSA-C22.2 No.60601-1 is Canada's national adoption of IEC 60601-1. AS/NZS 3551 is an Australian/New Zealand standard specifically covering the management, testing, and maintenance of medical electrical equipment in healthcare facilities — it applies to the facility's in-service management, not only to device design. A BIA device entering Australian hospitals must be IEC 60601-1 compliant by design and must be managed per AS/NZS 3551 once deployed.

Can a China-made BIA device meet Canadian and Australian regulatory requirements simultaneously?

Yes, provided the factory holds both a Health Canada MDALL licence (for the Canada pathway) and a TGA ARTG registration (for the Australia pathway), and the device is manufactured under ISO 13485:2016. Many Chinese factories serving export markets hold both registrations for their BIA product lines. Asaptic verifies both database listings before engaging any factory.

STANDARDS · COMPLIANCE · CANADA & AUSTRALIA

Medical Device Compliance Standards — Canada & Australia Comparison

Q: Does ISO 13485 alone satisfy Health Canada or TGA regulatory requirements?

No. ISO 13485 is a prerequisite quality management standard required by both Health Canada and TGA, but it does not substitute for the specific market-access listing. Health Canada requires an active MDALL licence for the specific device model; TGA requires an ARTG registration. ISO 13485 must be in scope for the device category and current (not expired). All three must be verified independently.

ISO 13485, IEC 60601-1, AS/NZS 3551, CAN/CSA-C22.2 No.60601-1, Health Canada MDALL, and TGA ARTG compared side-by-side. Informational reference for procurement teams evaluating China-made BIA devices for Canadian and Australian markets.

Clinical BIA Device Sourcing → Ask a Compliance Question

WHAT THIS PAGE ANSWERS

Procurement teams sourcing bioimpedance (BIA) devices from China into Canada or Australia face overlapping regulatory frameworks: a quality management standard (ISO 13485), electrical safety standards (IEC 60601-1 family), in-service management standards (AS/NZS 3551 for Australia), and mandatory market-access registries (Health Canada MDALL for Canada; TGA ARTG for Australia). This matrix sets out each standard's scope, its market applicability, and whether it applies to BIA devices — so procurement officers can confirm, in a single reference, which documents they need to request and verify.

Informational only. This page is a public-interest informational comparison. It is not a certification decision, legal advice, notified-body assessment, or market-access approval. Verify all requirements with the relevant regulatory authority (Health Canada; TGA) before procurement.

COMPLIANCE STANDARDS — SIDE-BY-SIDE COMPARISON

Standard	Market	Scope	Applies to BIA Devices?	Notes for Procurement
ISO 13485:2016	Global	Quality management system (QMS) for medical device manufacturers and supply chain. Covers design controls, production, traceability, post-market surveillance.	Yes — mandatory	Required by both Health Canada and TGA as evidence of systematic quality control. Certificate scope must explicitly cover the BIA device category — not a generic QMS covering unrelated product lines. Verify currency (expiry date) and certification body via the CB's public register. Included in Asaptic's compliance document package.
IEC 60601-1:2005+AMD1:2012+AMD2:2020	Global	General requirements for basic safety and essential performance of medical electrical equipment. Covers insulation, leakage current, mechanical strength, temperature limits, and essential performance under single fault condition.	Yes — by design	BIA devices are medical electrical equipment; IEC 60601-1 compliance is required by design and must be demonstrated by the manufacturer. The relevant national adoptions (CAN/CSA-C22.2 No.60601-1 for Canada; AS/NZS 3551 references IEC 60601-1 for base equipment requirements) supersede the base IEC text for market access. Test reports should reference the specific edition and amendment.
AS/NZS 3551:2012	Australia / New Zealand	Management programs for medical equipment in healthcare facilities. Covers acceptance testing, periodic safety checks, maintenance, repair, and decommissioning of in-service medical electrical equipment including BIA devices.	Yes — in-service	Applies once the device is deployed in an Australian or New Zealand healthcare facility — it governs the facility's management obligations, not the manufacturer's design obligations. Procurement teams should confirm their biomedical engineering department's AS/NZS 3551 acceptance testing protocol before specifying incoming device requirements. Facilities may require a documented test-before-use record.
CAN/CSA-C22.2 No.60601-1	Canada	Canadian national adoption of IEC 60601-1. General requirements for basic safety and essential performance of medical electrical equipment — functionally aligned with the IEC base standard, with any Canadian national deviations noted in the CSA adoption.	Yes — mandatory	For devices entering the Canadian market, compliance to CAN/CSA-C22.2 No.60601-1 is the applicable electrical safety requirement. Test reports should explicitly reference the CSA adoption, not only the base IEC standard, for Health Canada submissions. Factory test reports should list the edition and confirm no outstanding national deviations apply to the BIA device category.
Health Canada MDALL	Canada	Medical Devices Active Licence Listing — mandatory Class II medical device licence for devices sold in Canada. Covers device identity, manufacturer identity, and device class. Searchable at mdall.hc-sc.gc.ca.	Yes — market access	Without an active MDALL licence, a Class II BIA device cannot be legally sold in Canada. The licence is issued to the Canadian importer/distributor (or directly to the foreign manufacturer in some cases). Procurement officers should verify the specific device model and licence number — not just the manufacturer name — in the MDALL public database. Asaptic provides the verified licence number in the compliance document package.
TGA ARTG	Australia	Australian Register of Therapeutic Goods — Class IIa medical device registration required for devices legally supplied in Australia. Covers device description, sponsor identity, and ARTG entry number. Searchable at tga.gov.au/resources/artg.	Yes — market access	Without an ARTG entry, a Class IIa BIA device cannot be legally supplied in Australia. The ARTG registration is held by the Australian sponsor (importer). Procurement officers should verify the ARTG entry number, sponsor name, and device description in the TGA public portal — confirming it matches the shipped product. Asaptic provides the verified ARTG entry number and sponsor details in the compliance document package.
EU CE MDR (EU 2017/745)	European Union	EU Medical Device Regulation — Conformity assessment for medical devices placed on the EU market. Class IIa devices (where BIA typically falls) require notified body involvement.	Partial — EU only	CE MDR does not confer automatic market access in Canada or Australia — Health Canada and TGA each run independent regulatory pathways. CE MDR technical documentation (PMS plan, clinical evaluation) can support ISO 13485 and factory audit evidence packages but is not a substitute for MDALL or ARTG. Asaptic does not route CA/AU shipments through EU channels.

HOW THESE MAP FOR A CHINA-MADE BIA DEVICE

Selling a China-manufactured BIA device into Canada and Australia — the regulatory path.

The compliance stack for a Chinese factory supplying BIA devices to Canadian hospitals or Australian aged-care facilities involves four independent verification layers. All four must be in place before a procurement officer can confirm regulatory compliance for a tender submission.

Layer 1 — Factory QMS: ISO 13485:2016

The Chinese factory must hold a current ISO 13485:2016 certificate issued by an accredited certification body. The certificate scope must explicitly cover the BIA device category. Verify via the certification body's public register — not from a factory-supplied PDF scan. Asaptic verifies scope and currency before factory engagement.

Layer 2 — Device Electrical Safety: IEC 60601-1 family

The factory must demonstrate the BIA device meets IEC 60601-1 requirements. For Canada, the relevant adoption is CAN/CSA-C22.2 No.60601-1. For Australia, the base IEC 60601-1 standard applies to device design, with AS/NZS 3551 governing in-facility management. Test reports should reference the applicable edition and national adoption explicitly.

Layer 3 — Canada Market Access: Health Canada MDALL

The specific BIA device model must appear in the Health Canada MDALL database with an active Class II licence. Procurement officers verify at mdall.hc-sc.gc.ca using the licence number. The licence is issued to the Canadian importer or the foreign manufacturer directly — the importer chain must be confirmed. Asaptic provides the verified licence number in the document package.

Layer 4 — Australia Market Access: TGA ARTG

The specific BIA device model must appear in the TGA ARTG as a Class IIa device. Procurement officers verify at tga.gov.au/resources/artg using the ARTG entry number. The ARTG registration is held by the Australian sponsor — the sponsor identity and device description must match the shipped product. Asaptic provides the verified ARTG entry number and sponsor details in the document package.

In-Service (Australia): AS/NZS 3551

Once the BIA device is deployed in an Australian healthcare facility, the facility's biomedical engineering team applies AS/NZS 3551 management protocols: acceptance testing before first clinical use, periodic electrical safety checks, maintenance records, and decommissioning procedures. This is a facility-level obligation — procurement teams should confirm their biomedical engineering department's readiness before device delivery.

What CE MDR Does and Does Not Do

CE MDR certification from a Chinese factory is useful as supporting evidence (clinical evaluation, PMS plan, technical file quality) but does not confer Canadian or Australian market access. Health Canada and TGA each operate independent regulatory pathways. MDALL and ARTG listings must be verified separately — CE MDR does not substitute for either.

FREQUENTLY ASKED QUESTIONS

Compliance questions procurement officers ask most.

Does ISO 13485 alone satisfy Health Canada or TGA?

No. ISO 13485 is a prerequisite QMS standard required by both regulators, but it is not a market-access licence. Health Canada requires an active MDALL licence for the specific device model. TGA requires an ARTG registration. ISO 13485, the MDALL, and the ARTG are three separate verification steps — all must be confirmed independently.

Can one Chinese factory supply BIA devices to both Canada and Australia?

Yes, provided the factory holds both a Health Canada MDALL licence (for the Canada pathway) and a TGA ARTG registration (for the Australia pathway). Many Chinese factories serving export markets hold both for their BIA product lines. Asaptic verifies both database listings — by device model — before engaging any factory.

What is the difference between AS/NZS 3551 and IEC 60601-1?

IEC 60601-1 governs the design and manufacture of medical electrical equipment — it is a factory-level requirement. AS/NZS 3551 governs the in-service management of that equipment once deployed in an Australian healthcare facility — it is a facility-level requirement. Both apply to BIA devices in Australia, at different points in the device lifecycle.

Where do I verify a Health Canada MDALL or TGA ARTG listing?

Health Canada MDALL is publicly searchable at mdall.hc-sc.gc.ca — search by manufacturer name, device model, or licence number. TGA ARTG is publicly searchable at tga.gov.au/resources/artg — search by ARTG entry number, sponsor name, or device description. Both databases are authoritative government sources. Asaptic provides the specific licence and ARTG numbers so buyers can verify directly.

CLINICAL BIA SOURCING

Sourcing BIA devices for Canadian or Australian hospitals?

Asaptic sources bioimpedance devices directly from factories holding Health Canada Class II MDALL licences and TGA Class IIa ARTG registrations. The verified licence and ARTG numbers, ISO 13485 certificate, and full compliance document package are included with every shipment. See the full clinical device sourcing page for process and certification gate detail.

Clinical BIA Device Sourcing →